editorial high price of a newly approved cancer drug In Cancer Care, Cost Matters In Cancer Care, Cost Matters boycotted it, letter to the editor Op-Ed article an October, 2012 op-ed boycotted it, high price of a newly approved cancer drug penned a New York Times editorial op-ed in the New York Times boycotted it, op-ed in the New York Times, a month high price of a newly approved cancer drug a New York Times op-ed In Cancer Care, Cost Matters mismo medio In Cancer Care, Cost Matters New York Times Memorial Sloan-Kettering Cancer Center public attention to that action In Cancer Care, Cost Matters refused piece http://www.nytimes.com famosa carta In Cancer Care, Cost Matters http://www.nytimes.com New York Times In Cancer Care, Cost Matters